Steven J. Buhaly - 16 Feb 2023 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Chief Financial Officer
Signature
/s/ Steven J. Buhaly
Issuer symbol
BSGM
Transactions as of
16 Feb 2023
Net transactions value
$0
Form type
4
Filing time
17 Feb 2023, 14:03:22 UTC
Previous filing
08 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSGM Stock Option (Right to Buy) Award $0 +250,000 $0.000000 250,000 16 Feb 2023 Common Stock 250,000 $1.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options shall have a quarterly vesting schedule and shall become exercisable as of the date they vest, subject to the terms and conditions of the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan and the stock option agreement by and between the Company and the reporting person.